Medical Research News

RSS

Boosting manganese levels during pregnancy could potentially reduce preeclampsia risk

An analysis of data from more than 1,300 women followed prospectively through pregnancy found that women with lower levels of the essential mineral manganese in early pregnancy were more likely to develop the serious high blood pressure syndrome called preeclampsia in late pregnancy, according to a new study led by researchers from Johns Hopkins Bloomberg School of Public Health.

7 Jul 2020

Identification of shared and distinct brain structural signatures in psychiatric disorders

Researchers have previously identified brain structural signatures associated with individual neurological diseases using techniques such as magnetic resonance imaging (MRI).

7 Jul 2020

Risk of cerebral palsy in IVF children has declined by over 50% in the past 20 years

Fifteen years ago a large population study from Denmark found a significantly increased risk of cerebral palsy in infants born as a result of assisted reproduction.

7 Jul 2020

Researchers develop peptides for treating gastrointestinal disorders

The fascinating family of trefoil factor peptides brings hope to both research and industry to improve the treatment of chronic disorders such as Crohn's disease.

7 Jul 2020

Study: Animal proteins are more effective than plant proteins in building aging muscles

On a gram for gram basis, animal proteins are more effective than plant proteins in supporting the maintenance of skeletal muscle mass with advancing age, shows research presented this week at The Physiological Society's virtual early career conference Future Physiology 2020.

7 Jul 2020

Methotrexate is not an additional risk factor for interstitial lung disease in RA patients

Patients with rheumatoid arthritis (RA) often suffer from what is referred to as interstitial lung disease (ILD).

7 Jul 2020

Cancer Research UK and Abcam launch custom partnership to accelerate cancer research

Today, Cancer Research UK, the world’s largest independent funder of cancer research and Abcam plc, a global innovator in life science reagents and tools, are pleased to announce a new partnership for the development and commercialization of novel custom antibodies to support the acceleration of cancer research.

From Abcam 7 Jul 2020

Spike proteins of SARS-CoV-2 covered by mobile glycans that shield its surface

A new study of the structural dynamics of the SARS-CoV-2 spike protein published in the preprint server bioRxiv in July 2020 reports on the epitopes that could be possible immune targets for the development of vaccines.

7 Jul 2020

SARS-CoV-2 spike protein hidden as pH changes

Now, a new study published on the preprint server bioRxiv in July 2020 reports the role of pH in helping the virus escape neutralization by antibodies, by inducing a key conformational switch.

7 Jul 2020

New technique evaluates connectivity of brain networks in COVID-19 patients

Many patients with severe coronavirus disease in 2019 (COVID-19) remain unresponsive after surviving critical illness.

7 Jul 2020

People find non-round numbers unique and jarring, shows research

A vaccine for the novel coronavirus has been developed that is 91.27% effective. If public health officials present this information using the specific number, people are likely to think the vaccine is actually less effective than if it is presented as being 90% effective.

7 Jul 2020

Study may lead to novel therapeutic targets in certain memory disorders

To make new memories, our brain cells first must find one another. Small protrusions that bud out from the ends of neurons' long, branching tentacles dock neurons together so they can talk.

7 Jul 2020

Faulty immune response to SARS-CoV-2 one of the main causes of death

A new study published on the preprint server medRxiv in July 2020 describes the organ and tissue-specific spread of the virus causing the current COVID-19 pandemic, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

7 Jul 2020

Study reveals a new way to determine the age of insulin-storage parcels

A study in the Journal of Biological Chemistry describes a new way to determine the age of insulin-storage parcels, known as granules, and sheds light on how their age affects their release into the bloodstream.

7 Jul 2020

Neurobiologists correlate oxygen consumption with nerve cell activity

The brain has a high energy demand and reacts very sensitively to oxygen deficiency. Ludwig-Maximilians-Universitaet (LMU) in Munich neurobiologists have now succeeded for the first time in directly correlating oxygen consumption with the activity of certain nerve cells.

7 Jul 2020

SARS-CoV-2 detected in Santiago, Chile wastewater with very little loss of viral RNA

A preliminary report from Chile describes the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in sewage as a sensitive method to assess the circulation of viruses within a community.

7 Jul 2020

Dutch trial of convalescent plasma in COVID-19 discontinued

Now, a recent trial published on the preprint server medRxiv* in July 2020 reports that a majority of hospitalized COVID-19 patients have a high titer of neutralizing antibodies, at the time of admission, within 10 days of symptomatic disease.

7 Jul 2020

Viral and bacterial co-infections are pervasive in severe COVID-19 patients

A large group of researchers from China recently characterized microbial co-infections in the respiratory tract of hospitalized coronavirus disease (COVID-19) patients and demonstrated a high prevalence of both viral and bacterial co-infections – particularly in individuals presenting with severe disease.

6 Jul 2020

Airborne spread of SARS-CoV-2 possible and should not be ignored

Researchers at the National Institute for Public Health and the Environment in the Netherlands say that airborne transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is possible and should not be discounted.

6 Jul 2020

Doping agent Epo could be effective against Covid-19

Erythropoietin (Epo) is actually a medication for anaemia. According to researchers at the Max Planck Institute of Experimental Medicine in Göttingen, the doping agent Epo could also be effective against Covid-19.

6 Jul 2020